The Company is mainly engaged in pharmaceutical manufacturing, including pioglitazone hydrochloride tablets, the nateglinide tablets, metformin hydrochloride and glibenclamide tablets, sill hydrogen hydrochlorothiazide tablet, metformin hydrochloride sustained-release tablets, mecobalamin capsules and pioglitazone hydrochloride, that Geleg Nai, pharmaceutical raw materials and other products.
The Company was founded in October 29, 2004 December 8, 2014, the overall change of Limited by Share Ltd, in July 14, 2015 in the National SME share transfer system listed in circulation, the stock code is 832735.
The company was listed on the BEIJING STOCK EXCHANGE on February 19, 2021, with the stock code 832735.
Headquarters
Not disclosed to the official source.
Lianyungang; Jiangsu;
Postal Code: 222047
Contact Details: Purchase the Jiangsu Deyuan Pharmaceutical Co., Ltd report to view the information.
Website: http://www.pharmdy.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service